TBWA
BIIB icon

Three Bridge Wealth Advisors’s Biogen BIIB Stock Holding History

Three Bridge Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,444
Closed -$474K – 94
2024
Q3 		$474K Buy
2,444
+18
+0.7% +$3.77K 0.17% 60
2024
Q2 		$562K Sell
2,426
-103
-4% -$22.4K 0.22% 55
2024
Q1 		$545K Buy
2,529
+78
+3% +$18.3K 0.21% 60
2023
Q4 		$634K Sell
2,451
-769
-24% -$189K 0.22% 52
2023
Q3 		$828K Sell
3,220
-28
-0.9% -$7.49K 0.34% 48
2023
Q2 		$925K Sell
3,248
-277
-8% -$82.5K 0.39% 46
2023
Q1 		$980K Buy
3,525
+268
+8% +$74.2K 0.45% 43
2022
Q4 		$902K Sell
3,257
-774
-19% -$219K 0.48% 41
2022
Q3 		$1.08M Sell
4,031
-66
-2% -$14K 0.55% 38
2022
Q2 		$836K Sell
4,097
-85
-2% -$17.4K 0.41% 48
2022
Q1 		$881K Buy
+4,182
New +$909K 0.25% 47

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Three Bridge Wealth Advisors's BIIB Position: Q4 2024 in Review

Three Bridge Wealth Advisors sold out of Biogen (BIIB) in Q4 2024, closing a stake of 2,444 shares — an estimated $474K sold.

Three Bridge Wealth Advisors first reported a position in BIIB in Q1 2022 and held it in 11 quarters. The position peaked at $1.08M in Q3 2022. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Three Bridge Wealth Advisors reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Three Bridge Wealth Advisors sold 2,444 Biogen shares in Q4 2024, an estimated $474K.
  • Three Bridge Wealth Advisors first reported a position in Biogen in Q1 2022 and held it in 11 quarters.
  • Three Bridge Wealth Advisors's Biogen position peaked at $1.08M in Q3 2022.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Three Bridge Wealth Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.